Table 2 Bivariate analysis between baseline outcomes and hemorrhagic transformation PH type.
Outcome | No PH (n = 72) | Yes PH (n = 33) | P value |
|---|---|---|---|
Age | 73.1 ± 11.8 | 73.7 ± 11.3 | 0.81 |
Sex (female) | 35 (48.6%) | 12 (36.4%) | 0.24 |
Smoking (current or past) | 14 (19.4%) | 5 (15.2%) | 0.60 |
Alcohol consumption | 5 (6.9%) | 4 (12.1%) | 0.38 |
Hypertension | 51 (70.8%) | 21 (63.6%) | 0.46 |
Diabetes | 17 (23.6%) | 10 (30.3%) | 0.47 |
Dyslipemia | 22 (30.6%) | 12 (36.4%) | 0.56 |
Antiplatelets | 16 (22.2%) | 8 (24.2%) | 0.82 |
Anticoagulation | 13 (18.1%) | 9 (27.3%) | 0.28 |
Baseline NIHSS | 15 (9–19) | 19 (15–22) | 0.012 |
Known time of symptom onset | 51 (70.8%) | 20 (60.6%) | 0.30 |
Pretreatment blood glucose level | 130.13 ± 34.36 | 130.41 ± 33.50 | 0.97 |
Admission systolic blood pressure | 144.5 ± 23.9 | 152.2 ± 23.9 | 0.13 |
Admission dyastolic blood pressure | 77.5 ± 13.5 | 80.1 ± 12.3 | 0.35 |
Cardioembolic stroke | 33 (45.8%) | 19 (57.6%) | 0.44 |
Onset-to-door-time | 463 (323.5–688.3) | 655 (374.5–740.0) | 0.17 |
Door-to-CT-time | 22 (15.5–34.8) | 22(15.0–37.5) | 0.77 |
Door-to-puncture time | 98 (79.3–114.8) | 94 (74.5–110.5) | 0.67 |
Groin puncture-to last angiographic serie time | 40 (25–60) | 35 (17.5–87.5) | 0.74 |
General anesthesia | 54 (75%) | 15 (45.5%) | 0.003 |
Baseline ASPECTS | 9 (8–10) | 7 (6–8) | < 0.001 |
M1 Oclussion | 58 (80.6%) | 28 (84.8%) | 0.60 |
Complete recanalization (TICI 2b-3) | 66 (93%) | 26 (78.8%) | 0.04 |
Mean HU at affected hemisphere | 30.1 ± 3.7 | 28.3 ± 3.0 | 0.018 |
Mean HU at non-affected hemisphere | 32.6 ± 3.0 | 32.7 ± 2.1 | 0.94 |
Minimum HU | 29.2 ± 4.1 | 26.9 ± 3.7 | 0.008 |
Ischemic core’s hypodensity ratio | 0.91 (0.86–0.97) | 0.85 (0.82–0.89) | < 0.001 |
